Previous Article | Next Article ![]()
Molecular and Cellular Biology, December 2000, p. 8803-8814, Vol. 20, No. 23
Department of Pathology and Kaplan
Comprehensive Cancer Center, New York University School of
Medicine, New York, New York 10016,1 and
Institut Pasteur, 75724 Paris Cedex 15, France2
Received 15 May 2000/Returned for modification 5 July 2000/Accepted 29 August 2000
Interferon regulatory factor 7 (IRF7) is an interferon
(IFN)-inducible transcription factor required for activation of a
subset of IFN-
0270-7306/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Phosphorylation-Induced Dimerization of Interferon
Regulatory Factor 7 Unmasks DNA Binding and a Bipartite
Transactivation Domain
genes that are expressed with delayed kinetics
following viral infection. IRF7 is synthesized as a latent protein and
is posttranslationally modified by protein phosphorylation in infected cells. Phosphorylation required a carboxyl-terminal regulatory domain
that controlled the retention of the active protein exclusively in the
nucleus, as well as its binding to specific DNA target sequences,
multimerization, and ability to induce target gene expression.
Transcriptional activation by IRF7 mapped to two distinct regions, both
of which were required for full activity, while all functions were
masked in latent IRF7 by an autoinhibitory domain mapping to an
internal region. A conditionally active form of IRF7 was constructed by
fusing IRF7 with the ligand-binding and dimerization domain of estrogen
receptor (ER). Hormone-dependent dimerization of chimeric IRF7-ER
stimulated DNA binding and transcriptional transactivation of
endogenous target genes. These studies demonstrate the regulation of
IRF7 activity by phosphorylation-dependent allosteric changes that
result in dimerization and that facilitate nuclear retention, derepress
transactivation, and allow specific DNA binding.
*
Corresponding author. Mailing address: Department of
Pathology, New York University School of Medicine, 550 First Ave., New York, NY 10016. Phone: (212) 263-8192. Fax: (212) 263-8211. E-mail: levyd01{at}med.nyu.edu.
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|